Last Posted: Jul 26, 2018
- Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer A Secondary Analysis of a Randomized Clinical Trial
J Sparano et al, JAMA Oncology, July 26, 2018 - Cancer biomarker discovery for precision medicine: new progresses.
Zou Jinfeng et al. Current medicinal chemistry 2018 Jul - Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
Pi Can et al. Expert review of molecular diagnostics 2017 17(12) 1089-1096 - Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease.
Hong David K et al. Diagnostic microbiology and infectious disease 2018 Jun - Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.
Abbosh Christopher et al. Nature reviews. Clinical oncology 2018 Jul - Liquid biopsy: still early days for early detection
G Watts, Lancet, June 30, 2018 - Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids.
Neoh Kuang Hong et al. Biomaterials 2018 Jan 150112-124 - Cancer panel analysis of circulating tumor cells in patients with breast cancer.
Lee Cham Han et al. Oncology letters 2018 Jul 16(1) 612-618 - Mutation-counting blood test could predict if cutting-edge immunotherapies can beat a cancer
K Garber, Science, June 27, 2018 - Circulating Tumor DNA Assays in Clinical Cancer Research
MR Ossandon et al, JNCI, June 2018
.png)
No hay comentarios:
Publicar un comentario